Cargando…
Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities
Autores principales: | Manjaly Thomas, Zita-Rose, Leuppi-Taegtmeyer, Anne, Jamiolkowski, Dagmar, Steveling-Klein, Esther, Bellutti-Enders, Felicitas, Scherer Hofmeier, Kathrin, Hartmann, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833501/ https://www.ncbi.nlm.nih.gov/pubmed/32710973 http://dx.doi.org/10.1016/j.jaci.2020.07.008 |
Ejemplares similares
-
Hypersensitivity reactions to modern antiplatelet and anticoagulant drugs
por: Hofmeier, Kathrin Scherer
Publicado: (2015) -
Alpha-gal syndrome initially misdiagnosed as chronic spontaneous urticaria in a pediatric patient: a case report and review of the literature
por: Enders, Felicitas Bellutti, et al.
Publicado: (2023) -
Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports
por: Brockhaus, Lisa, et al.
Publicado: (2019) -
Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination
por: Tomayko, Mary M., et al.
Publicado: (2021) -
Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID‐19
por: Chandan, Joht Singh, et al.
Publicado: (2021)